Hepatocellular carcinoma and interferon therapy in HCV compensated cirrhosis: evaluation in relation to virological response.
Testino
Gianni
G
Icardi
Giancarlo
G
D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control* / Q000821:virology; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000187:drug effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000821:virology; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000517:prevention & control* / Q000821:virology; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D016896:Treatment Outcome
D016898:Interferon-alpha; D012367:RNA, Viral